Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 13, 2007
Chronic relapsing opsoclonus-myoclonus syndrome: combination of cyclophosphamide and dexamethasone pulsesB Wilken, M Baumann, C G Bien, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastomaH Christiansen, K Sahin, F Berthold, et al.
Klinische Padiatrie|April 29, 2005
Infants with stage 4 neuroblastoma: the impact of the chimeric anti-GD2-antibody ch14.18 consolidation therapyT Simon, B Hero, A Faldum, et al.
The American Journal of Pathology|January 1, 1997
Prognostic significance of the proliferative activity in neuroblastomaP Rudolph, T Lappe, B Hero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Which cases are found and missed by neuroblastoma screening at 1 year? Results from the 1992 to 1995 study in three Federal States of GermanyF Berthold, A Baillot, B Hero, et al.
Klinische Padiatrie|July 1, 1997
Does megatherapy contribute to survival in metastatic neuroblastoma? A retrospective analysis. German Cooperative Neuroblastoma Study GroupB Hero, B Kremens, T Klingebiel, et al.
Neuropediatrics|November 7, 2007
Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS)I Krasenbrink, V Fühlhuber, I Juhasz-Boess, et al.
Klinische Padiatrie|August 8, 2002
[Standardizing terminology in pediatric oncology--the basic data set]A Merzweiler, H Ehlerding, U Creutzig, et al.
Bone Marrow Transplantation|June 1, 2002
Isolation and transplantation of highly purified autologous peripheral CD34(+) progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastomaR Handgretinger, P Lang, K Ihm, et al.
Nuklearmedizin. Nuclear Medicine|September 12, 2006
Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004M Schmidt, T Simon, B Hero, et al.
Pageof 5